Loading clinical trials...
Loading clinical trials...
A Phase I Study of Cytosine Deaminase-Expressing Neural Stem Cells in Combination With Oral 5-Fluorocytosine and Leucovorin for the Treatment of Recurrent High-Grade Gliomas
Conditions
Interventions
E. coli CD-expressing genetically modified neural stem cells
flucytosine
+3 more
Locations
1
United States
City of Hope Medical Center
Duarte, California, United States
Start Date
October 7, 2014
Primary Completion Date
October 7, 2017
Completion Date
October 7, 2017
Last Updated
October 20, 2021
NCT01894061
NCT00662506
NCT01730950
NCT01478321
NCT02337426
NCT01575275
Lead Sponsor
City of Hope Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions